I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, CONBA announced that the company has received the Drug Registration Certificate for the throat lozenge approved and issued by the National Medical Products Administration (referred to as "NMPA"). The throat lozenge is an improvement on the already marketed throat mixture. The functions and indications of the throat lozenge include nourishing yin, clearing the throat, and detoxifying, used for treating acute pharyngitis classified as lung heat and yin deficiency syndrome in traditional Chinese medicine, characterized by throat pain (pain during swallowing), dry and burning throat, red tongue, thin coating, and thin pulse
According to the Zhitong Finance APP, CONBA (600572.SH) announced that the company has received the Drug Registration Certificate for the throat lozenge approved and issued by the National Medical Products Administration (referred to as "NMPA"). The throat lozenge is an improvement on the already marketed throat mixture. The functions and indications of the throat lozenge include nourishing yin, clearing the throat, and detoxifying, used for treating acute pharyngitis classified as lung heat and yin deficiency syndrome in traditional Chinese medicine, characterized by throat pain (pain during swallowing), dry and burning throat, red tongue, thin coating, and thin pulse